138 results
Page 3 of 7
8-K
EX-99.2
m1jk3c6wn
25 Feb 20
Paratek Pharmaceuticals Announces Full Year 2019 Total Revenues of $16.5 Million including NUZYRA® (omadacycline) Net Sales of $11.5 Million
4:05pm
8-K
EX-10.1
0q7vgpn9xgtei0 gg
2 Jul 19
Entry into a Material Definitive Agreement
5:22pm
8-K
EX-99.1
d626 g61gi6ao
27 Feb 19
Paratek Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results
4:39pm
8-K
EX-99.2
fembmea 81bjwpd9yf
27 Feb 19
Paratek Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results
4:39pm
8-K
mpiubxcxxt mt
27 Feb 19
Entry into a Material Definitive Agreement
9:24am
8-K
rim714izl as4k877w5w
4 Jan 19
Regulation FD Disclosure
5:20pm
8-K
EX-99.1
4gkivf5dsnrv
4 Jan 19
Regulation FD Disclosure
5:20pm
8-K
EX-99.1
v05i8r3p
6 Nov 18
Regulation FD Disclosure
4:05pm
8-K
EX-99.1
y9jbf18x1z 50s6
23 Oct 18
Regulation FD Disclosure
2:21pm